Clinical Study of the Efficacy and Safety of Liposomal Amphotericin B for the Treatment of Fungal Infections in Non-neutropenic Patients-Reference-Cited by-同舟云学术

Clinical Study of the Efficacy and Safety of Liposomal Amphotericin B for the Treatment of Fungal Infections in Non-neutropenic Patients

Published:2015 Issue:3 Volume:27 Page:147-153
ISSN:0915-6380
Container-title:The Showa University Journal of Medical Sciences
language:en
Short-container-title:Showa Univ J Med Sci

Author:

TANAKA Hironori¹²³,SUZUKI Ayako¹²,MARUMO Kenji¹⁴,HAYASHI Munetaka¹⁵,KOGO Mari²³,SAITO Isao⁶³,MURAYAMA Jun-Ichiro⁷³

Affiliation:

1. Division of Infection Control, Showa University Fujigaoka Hospital

2. Division of Pharmacy, Showa University Fujigaoka Hospital

3. Department of Hospital Pharmaceutics, Showa University, School of Pharmacy

4. Division of Central Clinical Laboratory, Showa University Fujigaoka Hospital

5. Department of Emergency and Critical Care Medicine, Showa University Fujigaoka Hospital

6. Division of Pharmacy, Showa University Karasuyama Hospital

7. Department of Pharmacy Services, Showa University Hospital

Publisher

The Showa University Society

Link

https://www.jstage.jst.go.jp/article/sujms/27/3/27_147/_pdf

Reference24 articles.

1. 1) Kume H, Yamazaki T, Abe M, et al. Epidemiology of visceral mycoses in patients with leukemia and MDS-Analysis of the data in annual of pathological autopsy cases in Japan in 1989, 1993, 1997 and 2001. Jpn J Med Mycol. 2006;47:15-24. (in Japanese).

2. 2) Shinzaisei Shinkinsho no Gaidorain Sakusei Iinkai ed. Guidelines for management of deep-seated mycose 2007. Tokyo: Kyowa Kikaku; 2007. (in Japanese).

3. 3) Myoken Y. Clinical pathogenesis of candidemia caused by non-albicans Candida species. Jpn J Med Mycol. 2009;50:225-228. (in Japanese).

4. 4) Tarumoto N, Abe Y, Yamaguchi T, et al. Clinical aspects of candidemia before and after the introduction of micafungin in Saitama Medical School Hospital. Jpn J Chemother. 2010;58:14-17. (in Japanese).

5. 5) Bates DW, Su L, Yu DT, et al. Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis. 2001;32:686-693.